PT  - JOURNAL ARTICLE
AU  - Park, Sehoon
AU  - Lee, Soojin
AU  - Kim, Yaerim
AU  - Cho, Semin
AU  - Kim, Kwangsoo
AU  - Kim, Yong Chul
AU  - Han, Seung Seok
AU  - Lee, Hajeong
AU  - Lee, Jung Pyo
AU  - Joo, Kwon Wook
AU  - Lim, Chun Soo
AU  - Kim, Yon Su
AU  - Kim, Dong Ki
TI  - Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study
AID  - 10.1101/2021.02.22.21252263
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.22.21252263
4099  - http://medrxiv.org/content/early/2021/04/02/2021.02.22.21252263.short
4100  - http://medrxiv.org/content/early/2021/04/02/2021.02.22.21252263.full
AB  - Background & aims An observational association between nonalcoholic fatty liver disease (NAFLD) and kidney function impairment has been reported. A genetic variant linked to an increased risk of NAFLD, the G allele of rs738409, has been reported to be associated with a reduction in estimated glomerular filtration rate (eGFR).Approach & Results In this Mendelian randomization (MR) study, we first performed single-variant MR with rs738409 as a genetic instrument to predict NAFLD. Another genetic instrument was developed from a previous genome-wide association study for the NAFLD phenotype in the Million Veteran Program cohort among individuals of European ancestry (68,725 cases and 95,472 controls). The eGFR outcome was assessed in individuals of white British ancestry included in the UK Biobank (N = 321,405). Further, the associations were reassessed in two negative control subgroups (body mass index < 25 kg/m2 and serum alanine aminotransferase level < 20 IU/mL) with a low probability of developing NAFLD. As a replication analysis, a summary-level MR was performed with the European ancestry CKDGen dataset (N = 567,460). In the UK Biobank dataset, a genetic predisposition for NAFLD, either by rs738409 or a group of variants, was significantly associated with a reduced eGFR even with adjustment for major metabolic disorders. Although the associations were not significant in the negative control subgroups with a low probability of developing NAFLD, they were significant in the subgroups with a remaining risk of NAFLD, suggesting the absence of a horizontal pleiotropic pathway. The summary-level MR from the CKDGen dataset supported the causal effects of NAFLD on reduced eGFR.Conclusions This MR analysis supports the causal reduction in kidney function by NAFLD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Industrial Strategic Technology Development Program - Development of biocore technology (Development of early diagnosis technology for acute/chronic renal failure) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea, 10077474). The study was performed independently by the authors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Boards of Seoul National University Hospital (E-2010-007-1160). The requirement for informed consent was waived as we investigated anonymous public databases. The investigation of the UK Biobank was approved by the consortium (No. 53799).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data for this study is available in the public domain.NAFLDnon-alcoholic fatty liver diesaseCKDchronic kidney diseaseeGFRestimated glomerular filtration rateMRMendelian randomizationPGSpolygenic score